{"id":1013102,"date":"2026-08-20T16:22:30","date_gmt":"2026-08-20T16:22:30","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1013102\/"},"modified":"2026-08-20T16:22:30","modified_gmt":"2026-08-20T16:22:30","slug":"enveda-moves-ahead-to-address-post-glp-1-weight-loss-maintenance-insights-citeline-com","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1013102\/","title":{"rendered":"Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance – insights.citeline.com"},"content":{"rendered":"
    \n
  1. Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance<\/a>  insights.citeline.com<\/li>\n
  2. Enveda\u2019s exercise-simulating obesity tablet clears early clinical test<\/a>  BioSpace<\/li>\n
  3. A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass<\/a>  STAT<\/li>\n
  4. Enveda Reports Positive Phase 1 Results for ENV-308, the First Pill Designed From the Chemistry of Exercise<\/a>  Business Wire<\/li>\n
  5. Enveda to move AI-discovered drug into mid-stage study for weight-loss maintenance<\/a>  FirstWord Pharma<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"Enveda Moves Ahead To Address Post-GLP-1 Weight Loss Maintenance  insights.citeline.com Enveda\u2019s exercise-simulating obesity tablet clears early clinical test  BioSpace A…\n","protected":false},"author":3,"featured_media":1013103,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[3738,210,1060,47692,10943,371517,67,132,68],"class_list":["post-1013102","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-clinical-trials","tag-health","tag-medication","tag-metabolic-disorders","tag-obesity","tag-research-development","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117128760428334573","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1013102","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1013102"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1013102\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1013103"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1013102"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1013102"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1013102"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}